GOLETA, Calif.—August 15, 2022—Transphorm, Inc. (NASDAQ: TGAN)—a pioneer in and global supplier of high-reliability, high-performance gallium nitride (GaN) power conversion products, announced today financial results from its 2023 fiscal first quarter that ended on June 30, 2022.
Fiscal First Quarter And Recent Highlights
“We continue to see strong traction in our targeted markets with record product bookings in the first quarter contributing to our strong backlog position,” commented Primit Parikh, Transphorm’s President, COO, and Co-founder. “In the near term, we continue to encounter supply chain challenges, including those related to COVID restrictions in the Asia region, that we expect to impact product revenue growth for the next two quarters. We have taken steps to mitigate these issues in the future. In July, we purchased two additional MOCVD reactors, and we anticipate bringing these reactors into production during the second half of calendar year 2023, helping us to further meet demand and build upon our high-power GaN leadership position.”
Parikh continued, “With our wide range of product offerings and notably high power GaN, Transphorm is well-positioned to grow across multiple markets – including consumer, data centers, blockchain, industrial, two and three-wheeler EVs and, in the longer term, the broader EV market. Revenue traction exists today in several of these markets including consumer, data centers, blockchain and industrial applications, and we have now grown product revenue 10 quarters in succession.”
Cameron McAulay, CFO of Transphorm, added, “With the recent exercise of the greenshoe, our balance sheet was strengthened even further and we ended the quarter with $43 million in cash and cash equivalents. This will enable us to continue to invest in the growth engines across all aspects of the company – both from a staffing and a capacity perspective.”
Fiscal 2023 First Quarter Financial Results
Revenue for the 2023 fiscal first quarter was $5.2 million, compared to $4.9 million in the 2022 fiscal fourth quarter ended March 31, 2022 and $3.2 million in the 2022 fiscal first quarter ended June 30, 2022. Revenue for the quarter reflected yet another record in product sales from ramping shipments of GaN devices for a broad range of power conversion applications, with a 10% sequential increase from the prior quarter. For the first fiscal quarter of 2023, product sales increased 101% as compared to the first fiscal quarter of 2022.
Operating expenses on a GAAP basis were $6.1 million in the 2023 fiscal first quarter, compared to $5.6 million in the prior quarter and $5.3 million in the 2022 fiscal first quarter. 2023 fiscal first quarter operating expenses consisted of R&D expenses of $1.7 million and SG&A expenses of $4.4 million. On a non-GAAP basis, operating expenses in the 2023 fiscal first quarter were $5.4 million, compared with non-GAAP operating expenses of $4.7 million in the prior quarter and $4.6 million in the 2022 fiscal first quarter.
GAAP net profit (loss) for the 2023 fiscal first quarter was ($5.4) million, or ($0.10) per share, compared to GAAP net loss of ($5.0) million, or ($0.09) per share, in the prior quarter, and GAAP net loss of ($7.1) million, or ($0.17) per share, in the 2022 fiscal first quarter. On a non-GAAP basis, net loss for the 2023 fiscal first quarter was ($4.5) million, or ($0.08) per share, compared to non-GAAP net loss of ($4.0) million, or ($0.08) per share, in the prior quarter, and non-GAAP net loss of ($5.3) million, or ($0.13) per share, in the 2022 fiscal first quarter.
Cash and equivalents as of June 30, 2022 were $43.1 million, compared to $2.5 million at June 30, 2021.
Transphorm will host a webcast today at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) to review the Company’s 2023 fiscal first quarter results and provide a business update. The webcast can be accessed at: https://events.q4inc.com/attendee/914330044
Investors and analysts may also join the conference call by dialing: 1 (888) 330-2446 or 1 (240) 789-2732 and providing the conference ID: 8060388.
A replay and the supporting presentation materials will be available on the day of the conference call and for approximately 90 days on the “Investors” section of the Company’s website. Additionally, a telephone replay of the conference call will be available after the conclusion of the call and through August 31, 2022. The telephone replay can be accessed by dialing 1 (800) 770-2030 and entering the conference ID: 8060388.
Transphorm, Inc., a global leader in the GaN revolution, designs and manufactures high performance and high reliability GaN semiconductors for high voltage power conversion applications. Having one of the largest Power GaN IP portfolios of more than 1,000 owned or licensed patents, Transphorm produces the industry’s first JEDEC and AEC-Q101 qualified high voltage GaN semiconductor devices. The Company’s vertically integrated device business model allows for innovation at every development stage: design, fabrication, device, and application support. Transphorm’s innovations are moving power electronics beyond the limitations of silicon to achieve over 99% efficiency, 40% more power density and 20% lower system cost. Transphorm is headquartered in Goleta, California and has manufacturing operations in Goleta and Aizu, Japan. For more information, please visit www.transphormusa.com. Follow us on Twitter @transphormusa and WeChat @ Transphorm_GaN.
Non-GAAP Financial Measures
This press release includes and makes reference to certain non-GAAP financial measures. The presentation of this financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.
Transphorm believes that the presentation of non-GAAP financial measures provides important supplemental information to management and investors regarding financial and business trends relating to the Company’s financial condition and results of operations. Transphorm believes that these non-GAAP financial measures provide additional insight into Transphorm’s ongoing performance and core operational activities and has chosen to provide these measures for more consistent and meaningful comparison between periods. These measures should only be used to evaluate Transphorm’s results of operations in conjunction with the corresponding GAAP measures. The non-GAAP results exclude the effect of stock-based compensation, depreciation, amortization, and changes in fair value of promissory note.
A reconciliation between GAAP and non-GAAP financial results is provided in the financial statements portion of this press release.
This press release contains forward-looking statements (including within the meaning of Section 21E of the United States Securities Exchange Act of 1934, as amended, and Section 27A of the United States Securities Act of 1933, as amended) concerning the Company’s ability to manage supply chain constraints, the Company’s expectations around the timing of bringing additional MOCVD reactors into production, the Company’s market positioning the Company’s pipeline and future anticipated growth. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “may,” “will,” “should,” “would,” “expect,” “plan,” “believe,” “intend,” “look forward,” and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: risks related to Transphorm’s operations, such as additional financing requirements and access to capital; competition; the ability of Transphorm to protect its intellectual property rights; and other risks set forth in the Company’s filings with the Securities and Exchange Commission. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.